medline.ch Onkologie Gynäkologische Tumoren

	(68)Ga-HER2 PET/CT for Predicting Pathologic Response to Neoadjuvant Therapy at Early Treatment and Preoperative Stages in HER2-Positive Breast Cancer: A Prospective Study. J Nucl Med Gao S, Zhang Z, Shi C, Cheng C, Ma X, Zhao X, Liu Y. PMID: 42562610 [PubMed - as supplied by publisher]
	Inflammatory breast cancer: improving research and care through the integration of preclinical evidence and technological advances. Crit Rev Oncol Hematol Nicolo E, Manai M, Soliman A, Reduzzi C, Cristofanilli M. PMID: 42562246 [PubMed - as supplied by publisher]
	Precision neoadjuvant treatment with AI-assisted subtyping in HR+/HER2-breast cancer: A randomized, phase 2 trial FASCINATE-N. Cell Rep Med Li JJ, Ma LX, Ji P, Chen L, Wu J, Liu GY, Hou YF, Di GH, Hu Z, Jiang YZ, Fan L, Wang ZH, Yu KD, Zhi-Ming Shao. PMID: 42561949 [PubMed - as supplied by publisher]
	Diagnostic specificity of the novel marker TRPS1 compared with traditional breast-specific markers in differentiating metastatic breast carcinoma from adrenal neoplasms. Ann Diagn Pathol Lobo A, Wu DJ, Sangoi AR. PMID: 42561593 [PubMed - as supplied by publisher]
	Automated segmentation of pretreatment computed tomography for evaluating intersite radiomic heterogeneity between platinum-resistant and platinum-sensitive ovarian cancer cohorts: a proof of concept study. Eur J Obstet Gynecol Reprod Biol Jacob A, Harichandrakumar KT, Sunitha VC, Ganesan P, Veena P. PMID: 42561578 [PubMed - as supplied by publisher]
	Moderating Role of Perceived Neighborhood Environment on Physical Activity and BMI Outcomes of a Diet and Physical Activity Intervention Among Latina Breast Cancer Survivors. J Phys Act Health Hill CM, Rillamas-Sun E, Marín-Chollom AM, Ulanday KT, Koch PA, Contento IR, Ogden Gaffney A, Hershman DL, Greenlee H. PMID: 42562369 [PubMed - as supplied by publisher]
	F11 Receptor/Junctional Adhesion Molecule-A: a novel therapeutic target in breast cancer. Biochimie Bednarek R, . PMID: 42562075 [PubMed - as supplied by publisher]
	Induced and spontaneous uterine leiomyomas in animal models: a scoping review. Acta Cir Bras Sousa WB, Nogueira Neto J, Araújo KMC, Gomes LMRS, Cartagenes MDSS, Garcia JBS. PMID: 42561311 [PubMed - indexed for MEDLINE]
	MicroRNA-204 and microRNA-652-3p as promising biomarkers for endometrial cancer diagnosis and prognosis. Rev Assoc Med Bras (1992) Minareci Y, Sözen H, Toyran A, Kucukgergin C, Ayd, Bingul , Gunver MG, Akkoyunlu SZ, Topuz S, Salihoglu MY. PMID: 42561202 [PubMed - indexed for MEDLINE]
	The association of total oxidant status, total antioxidant status, and ischemia-modified albumin levels with cervical human papillomavirus infection and cervical intraepithelial neoplasia. Rev Assoc Med Bras (1992) Ucok BS, Kinay T, Kusabbi IA, Dereli ML, Sucu S, Aktas TD, Ozalp E, Akbulut OV, Korkmaz V, Ustun YE. PMID: 42561193 [PubMed - indexed for MEDLINE]
	WDCN: a comprehensive neural network based approach for estimating breast cancer risk. Brief Bioinform Xu H, Zhang G, Lin H, Grosser M, Lu J. PMID: 42561150 [PubMed - indexed for MEDLINE]
	Combined prediction of anthracycline-induced cardiotoxicity in patients with breast cancer using neutrophil-to-lymphocyte ratio and left atrial reservoir strain: A prospective observational study. J Int Med Res Shao P, Wu Z, Liu X, Yao C, Li Y, Zhang B, Liu Z. PMID: 42561098 [PubMed - indexed for MEDLINE]
	Optimizing the MRI Pelvis Protocol for O-RADS MRI. Radiographics Tong A, Kim N, Patel-Lippmann K, Nougaret S, Reinhold C, Rockall AG, Thomassin-Naggara I, Sadowski EA. PMID: 42560824 [PubMed - indexed for MEDLINE]
	Electronic Patient-Reported Outcome Monitoring With Alert-Based Interventions in Metastatic Breast Cancer: A Randomized Clinical Trial. JAMA Oncol Karsten MM, Gebert P, Pross T, Hage AM, Dordevic AD, Stephan S, Kühn F, Doppelbauer L, Blohmer JU, Fischer F, Rose M, Pöhlmann A, Materne B, Petersen MA, Pauler L, Ferencz J, Wesselmann S, Breidenbach C, Grittner U, Kowalski C. PMID: 42560727 [PubMed - as supplied by publisher]
	Integrative analysis of TCGA data identifies hsa-miR-200a as a breast cancer-associated microRNA biomarker with exploratory serum validation. Genes Genomics Park K, Kim EY, Lee EJ, Nam H, Park HW, Lee EH, Kim H, Lee KE, Jeon D, Kim J. PMID: 42560646 [PubMed - as supplied by publisher]
	A novel tRNA-derived fragment, tRF-19-79MP9PJZ, promotes uterine corpus endometrial carcinoma progression by targeting DSC3. Hum Cell Jiang H, Jiang T, Shen Y, Jiang H, Yuan Q. PMID: 42560623 [PubMed - indexed for MEDLINE]
	Prognostic value of post-neoadjuvant pathological response and residual disease in early breast cancer: a real-world cohort study. Clin Transl Oncol Ferro A, Campora M, Eccher C, Lorenzi M, Biondi R, Caldara A, Cantarelli S, Campregher M, Carbone G, De Lisi D, Dipasquale M, Lazzeri S, Monteverdi S, Armatura G, De Rose F, Gori S, Valentini M, Caffo O. PMID: 42560581 [PubMed - as supplied by publisher]
	CDK4/6 Inhibitors in Breast Cancer Therapy: Mechanisms, Resistance, and Emerging Opportunities. Target Oncol Chinea L, Hauer C, Pal K, Chang HL, Chan IS. PMID: 42560566 [PubMed - as supplied by publisher]
	P-VERIFY: Real-World Comparative Overall Survival and Progression-Free Survival of CDK4/6 Inhibitors Plus an Aromatase Inhibitor in Patients with HR+/HER2- Metastatic Breast Cancer in the USA-A Vodcast. Target Oncol Rugo HS, Ryan JC. PMID: 42560565 [PubMed - as supplied by publisher]
	Optimising screening intervals and BI-RADS management pathways in ultrasound-based breast cancer screening: real-world evidence from Shenzhen (2018-2023). Breast Cancer Res Treat Sun W, Li H, Zhao X, Hu S, Qi H, Jin S, Zhang W, Zhao F. PMID: 42560548 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 333276

Seite 1 von 16664

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung